A growing body of research suggests that natural cognitive boosters, such as those high in omega-3 fatty acids [1], may be… https://www.Drugchatter.com/chat/51408/can-lipitor-be-replaced-with-natural-cognitive-boosters/
DrugChatter: Can lipitor be replaced with natural cognitive boosters? Read Post »
Generic drugmakers don’t “wait their turn.” They litigate their way to it.
If you’ve ever wondered how some generics hit the market faster than expected, the answer often isn’t manufacturing capacity or regulatory luck—it’s patent strategy.
In a rece…
The real battleground in pharma isn’t patent expiry—it’s what you do before it.
As soon as a drug’s exclusivity window starts to narrow, the market stops rewarding “good enough” and starts rewarding speed, certainty, and defensibility. That’s why abu…
Old Drugs, New Signals: What the Side-Effect Conversation Is Really Saying
The side-effect conversation is getting louder—and it’s not just about safety.
Over the past few years, “old drugs” have been showing up in new places: in fresh clinical analyse…
Old Drugs, New Signals: What the Side-Effect Conversation is Really Saying Read Post »
A drug patent isn’t “worth” what the spreadsheet says—it’s worth what it can survive.
In M&A, everyone talks about patent life, exclusivity windows, and peak sales. But the real value of a drug patent often comes down to a less glamorous line ite…
What a Drug Patent Is Really Worth: How Litigation Costs Reshape Acquisition Value Read Post »
Most NDAs Don’t Fail on Science. They Fail on Strategy.
In pharma, we love to talk about molecules—mechanisms, trial design, endpoints, and the elegance of the data. But anyone who’s shepherded an NDA knows the uncomfortable truth: the submission is …
Two clocks. One drug. And a lot of investors betting on the wrong one.
In pharma, timing isn’t just strategy—it’s destiny. Yet too many teams (and too many market narratives) treat “patent expiry” as the finish line. It isn’t.
A recent DrugPatentWatch …
Advil Dual Action, a pain relief medication combining ibuprofen and aspirin, is designed to provide fast and effective relief… https://www.Drugchatter.com/chat/61409/how-quickly-does-advil-dual-action-work/
DrugChatter: How quickly does advil dual action work? Read Post »
Keytruda, also known as pembrolizumab, is a cancer medication developed by Merck & Co. The US Food and Drug Administration… https://www.Drugchatter.com/chat/26764/what’s-the-exact-date-of-keytruda’s-first-fda-approval/
DrugChatter: What’s the exact date of keytruda’s first fda approval? Read Post »
Keytruda, also known as pembrolizumab, is a cancer medication developed by Merck & Co. The US Food and Drug Administration… https://www.Drugchatter.com/chat/26764/what’s-the-exact-date-of-keytruda’s-first-fda-approval/
DrugChatter: What’s the exact date of keytruda’s first fda approval? Read Post »
Get new actionable insights and updates from BiotechBlog
